Endo International PLC ENDP:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:41 PM EDT
0.53quote price arrow down-0.01 (-2.52%)
Volume
560,342
Close
0.5437quote price arrow up+0.0237 (+4.56%)
Volume
68,039,110
52 week range
0.28 - 7.07
Loading...
  • Open0.5055
  • Day High0.56
  • Day Low0.47
  • Prev Close0.52
  • 52 Week High7.07
  • 52 Week High Date11/11/21
  • 52 Week Low0.28
  • 52 Week Low Date06/16/22

Key Stats

  • Market Cap127.83M
  • Shares Out235.11M
  • 10 Day Average Volume129.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-85.54

KEY STATS

  • Open0.5055
  • Day High0.56
  • Day Low0.47
  • Prev Close0.52
  • 52 Week High7.07
  • 52 Week High Date11/11/21
  • 52 Week Low0.28
  • 52 Week Low Date06/16/22
  • Market Cap127.83M
  • Shares Out235.11M
  • 10 Day Average Volume129.95M
  • Dividend-
  • Dividend Yield-
  • Beta1.12
  • YTD % Change-85.54

RATIOS/PROFITABILITY

  • EPS (TTM)-2.92
  • P/E (TTM)-0.19
  • Fwd P/E (NTM)1.34
  • EBITDA (TTM)1.14B
  • ROE (TTM)-368.12%
  • Revenue (TTM)2.928B
  • Gross Margin (TTM)71.76%
  • Net Margin (TTM)-23.28%
  • Debt To Equity (MRQ)-617.13%

EVENTS

  • Earnings Date08/08/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Endo International PLC

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Endo International plc is a specialty pharmaceutical company. The Company operates through four business segments: Branded Pharmaceuticals, Sterile Injectables, Generic Pharmaceuticals and International Pharmaceuticals. Its Branded Pharmaceuticals segment includes a variety of branded products in the areas of urology, orthopedics, endocrinology, medical aesthetics and bariatrics, among others. Its products include XIAFLEX, SUPPRELIN LA, NASCOBAL Nasal Spray, AVEED, QWO...
Mark Barberio
Independent Non-Executive Chairman of the Board
Blaise Coleman
President, Chief Executive Officer, Director
Mark Bradley
Chief Financial Officer, Executive Vice President
Matthew Maletta
Executive Vice President, Chief Legal Officer, Company Secretary
Patrick Barry
Executive Vice President, President, Global Commercial Operations
Address
Minerva House, Simmonscourt Road
Dublin
000 00
Ireland

Top Peers

SYMBOLLASTCHG%CHG
AMRX
Amneal Pharmaceuticals Inc
3.22-0.10-3.01%
EBS
Emergent BioSolutions Inc
32.84-0.42-1.26%
PAHC
Phibro Animal Health Corp
19.64-0.51-2.53%
AMRN
Amarin Corporation PLC
1.56-0.03-1.89%
LCI
Lannett Company Inc
0.575-0.0004-0.0695%